Nasopharyngeal carcinoma (NPC) is a rare type of head and neck cancer. Potential risk factors include certain lifestyle factors and exposure to Epstein-Barr virus. Symptoms and treatment vary, but the ...
A novel biomarker derived from Epstein-Barr virus (EBV) significantly improved the diagnostic accuracy for nasopharyngeal carcinoma, a large screening study from China showed. Screening with P85-Ab, ...
Health Canada has approved a new treatment for adults with recurrent or metastatic nasopharyngeal carcinoma, a rare form of head and neck cancer, the company behind the treatment said in a statement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback